AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Discover credit cards that provide cash rewards without annual fees. Make your spending count!
26,108 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Floating-rate Treasuries have provided steadier income as rate volatility persists. This piece examines how USFR deli...
A high-profile Miami pop-up marks more than a fashion moment. This article dives into how Victoria Beckham Appears Ex...
Berkshire Hathaway’s surprise Alphabet investment signals a bold, long-term bet from Buffett. Learn the reasoning, ri...
A small AI-focused player claims it helps customers turn modest marketing spend into impressive gains. This piece bre...
Investors are rechecking fintech momentum as the stock market today, feb. delivers a choppy session. This guide break...
If you’re considering where to put $1,000 right now, Newmont isn’t just about gold — it’s about exposure to a volatil...
Netflix delivers a brighter quarterly outlook and improved unit economics, fueling a fresh rally as investors bet on ...
Markets swing wildly during downturns, testing nerves and portfolios. Here are three stock market turmoil: crucial st...
Microsoft kicks off 2026 with a rough start as earnings beat clashes with a surge in capital expenditures. Traders de...
In a choppy market, SPHD delivers income built bear markets through a defensive mix of high-dividend, low-volatility ...
The S&P 500 just completed straight week, marking a notable stretch of gains. This article breaks down what it could ...